We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Physicians Question Lowering of BMI Requirements for Bariatric Surgery

By HospiMedica International staff writers
Posted on 12 Jan 2011
The American Society of Bariatric Physicians (ASBP; Aurora, CO, USA) has expressed concern that at the same time that an advisory panel of the US Food and Drug Administration (FDA, Silver Spring, MD, USA) recommended lowering the body mass index (BMI) requirement for lap-band surgery, the FDA has denied two new obesity medications. More...


The ASBP stated that it supports medically supervised weight loss programs as the treatment of choice for patients with BMIs between 30 and 35, and believes that the new recommendation of lap-band surgery for patients with BMIs of 30 and above is premature, and carries risks that have not yet been considered. The ASBP further added that bariatric surgery is drastic and expensive, and carries higher morbidity and mortality risks than lifestyle interventions or medication. Thus, patients who could have otherwise lost weight in a nonsurgical medical bariatric program may now be encouraged to skip medical therapy and jump directly to surgery.

Before a patient ever considers surgery, the ASBP advocates that the patient first seek the help of a qualified bariatric physician, who will start with a complete patient work-up, ensuring that metabolic and overall health are not compromised. Proper implementation of a medically managed weight loss program by a bariatric physician can lead to tremendous success, with long-term reversal of obesity related comorbidities equivalent to surgical interventions, minus the risks.

"The ASBP concludes that bariatric surgery is not a quick fix or an easy answer to the obesity epidemic,” the statement reads. "Bariatric surgery has been and should remain a second line therapy after comprehensive medically-managed weight loss. Bariatric surgery does not end one's challenges with weight; rather, it creates new and different nutritional, medical, and psychiatric challenges that must be carefully considered.”

Bariatric surgery is often accompanied by side effects and substantial failure rates. Almost 30% of bariatric surgery patients regain the weight they initially lost or have the surgery reversed, according to long-term studies, and a recent study found that there was a five-fold increase of suicides among all patients who had bariatric surgery, most occurring within three years following the surgery. Weight loss surgery also causes nutritional deficiencies requiring lifelong supplementation of calcium, vitamin B12, folate, multivitamins, iron, and thiamine.

Related Links:

American Society of Bariatric Physicians
US Food and Drug Administration



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.